Clinical Trials Directory

Trials / Completed

CompletedNCT03534089

Effectiveness of the Treatment for Infant Iron Deficiency Anemia by Taking Lactoferrin and Ferralia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
135 (actual)
Sponsor
Beingmate Baby & Child Food Co Ltd . · Academic / Other
Sex
All
Age
5 Months – 9 Months
Healthy volunteers
Not accepted

Summary

A multi-center,randomized,double-blind,controlled clinical trial was used to investigate the effectiveness of the treatment of infant iron deficiency anemia by taking ferralia and different contents lactoferrin.

Detailed description

5-9 months old infants with iron deficiency anemia were randomly divided into three groups. On the basis of giving the same dose of ferralia,three different levels lactoferrin infant formula were intervened 3 months respectively,and evaluate the clinical effect.

Conditions

Interventions

TypeNameDescription
OTHERStandard infant fomulaInfants with iron deficiency anemia randomly divided into this group were given the same dose of ferralia with other groups,and were fed with infant formula without lactoferrin supplementation.
OTHERLow level LF infant formulaInfants with iron deficiency anemia randomly divided into this group were given the same dose of ferralia with other groups,and were fed with infant formula supplemented with low level of lactoferrin (38mg/100g).
OTHERHigh level LF infant formulaInfants with iron deficiency anemia randomly divided into this group were given the same dose of ferralia with other groups,and were fed with infant formula middle supplemented with high level of lactoferrin (76mg/100g).

Timeline

Start date
2017-02-01
Primary completion
2017-10-31
Completion
2017-10-31
First posted
2018-05-23
Last updated
2018-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03534089. Inclusion in this directory is not an endorsement.